What's in ImmunoVaccine Technologies, Inc. (IMV Inc.)'s pipeline?

ImmunoVaccine Technologies, Inc. (IMV Inc.) has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with ImmunoVaccine Technologies, Inc. (IMV Inc.)'s portfolio?

Top competitors by shared drug class: CancerVax Corporation, Centre Leon Berard, Chiang Mai University, Chiltern Pesquisa Clinica Ltda, GERCOR - Multidisciplinary Oncology Cooperative Group.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/immunovaccine-technologies-inc-imv-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

ImmunoVaccine Technologies, Inc. (IMV Inc.) — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ImmunoVaccine Technologies, Inc. (IMV Inc.) pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
CPA	CPA	marketed	Therapeutic cancer vaccine		Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

CancerVax Corporation · 1 shared drug class
Centre Leon Berard · 1 shared drug class
Chiang Mai University · 1 shared drug class
Chiltern Pesquisa Clinica Ltda · 1 shared drug class
GERCOR - Multidisciplinary Oncology Cooperative Group · 1 shared drug class
Galena Biopharma, Inc. · 1 shared drug class
Genocea Biosciences, Inc. · 1 shared drug class
GlaxoSmithKline · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for ImmunoVaccine Technologies, Inc. (IMV Inc.):

Cite this brief

Drug Landscape (2026). ImmunoVaccine Technologies, Inc. (IMV Inc.) — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/immunovaccine-technologies-inc-imv-inc. Accessed 2026-05-16.